Crisanto Torres: Early Plasma Administration Maximizes Survival in Traumatic Intracranial Hemorrhage
Crisanto Torres, Assistant Professor of Surgery at Assistant Professor of Surgery shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Trauma and Acute Care Surgery, adding:
“In this study mentee and future Beth Israel Deaconess surgery resident, Heejoo Kang, we found that, among patients with traumatic intracranial hemorrhage, there is an associated time – survival relationship.
The greatest survival benefit was seen when plasma was given within 30 minutes of hospital arrival.
Beyond this, survival benefit plateaued, with a 5 percent absolute decrease per 10 – minute delay, and the risk of neurosurgical interventions increased.”
Title: Association of plasma transfusion timing with mortality among patients with traumatic intracranial hemorrhage across US adult civilian trauma centers
Authors: Heejoo Kang, Charlene Ong, Kelly Kenzik, Tehnaz Boyle, Dane Scantling, Noelle Saillant, James Feldman, Crisanto Torres
Stay updated on all scientific advances Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight